-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PWHTSlD0sQRp+ZqVp3EIIJu31PlPT85kPKQpTB6s6Hjn9cspTfm3HT/REbqyveK4 S+o5+sbqbNhMNkacmQAHdw== 0001193125-04-159915.txt : 20040922 0001193125-04-159915.hdr.sgml : 20040922 20040922092428 ACCESSION NUMBER: 0001193125-04-159915 CONFORMED SUBMISSION TYPE: 8-A12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040922 DATE AS OF CHANGE: 20040922 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ANTARES PHARMA INC CENTRAL INDEX KEY: 0001016169 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411350192 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-A12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-32302 FILM NUMBER: 041040305 BUSINESS ADDRESS: STREET 1: 707 EAGLEVIEW BOULEVARD STREET 2: SUITE 414 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 610-458-6200 MAIL ADDRESS: STREET 1: 707 EAGLEVIEW BOULEVARD STREET 2: SUITE 414 CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/ DATE OF NAME CHANGE: 20010604 FORMER COMPANY: FORMER CONFORMED NAME: MEDI JECT CORP /MN/ DATE OF NAME CHANGE: 19960605 8-A12B 1 d8a12b.htm FORM 8-A 12(B) Form 8-A 12(b)

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

ANTARES PHARMA, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Minnesota   41-1350192
(State of Incorporation   (I.R.S. Employer
or Organization)   Identification No.)

 

707 Eagleview Boulevard, Suite 414

Exton, PA 19341

(Address of Principal Executive Offices)

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A. (c), check the following box. x

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A. (d), check the following box. ¨

 

Securities Act registration statement file number to which this form relates: [Not Applicable]

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

To Be So Registered

  

Name of Each Exchange On Which

Each Class Is To Be Registered

Common Stock, par value $.01 per share

   American Stock Exchange

 

Item 1. Description of Registrant’s Securities to be Registered.

 

The Registrant incorporates by reference the description of its common stock included in the Registrant’s Registration Statement on Form S-1/A (Registration No. 333-6661), filed with the Securities and Exchange Commission on August 15, 1996, including any amendment or report filed for the purpose of updating such description.

 

Item 2. Exhibits.

 

None.

 

SIGNATURES

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

Date: September 22, 2004       Antares Pharma, Inc.
        By:  

/s/ Jack Stover

               

Jack Stover

                Chief Executive Officer

 

 -----END PRIVACY-ENHANCED MESSAGE-----